A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

Condition:   Sever Aplastic Anaemia Intervention:   Drug: Hetrombopag Olamine Tablet Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Completed

Source: ClinicalTrials.gov - October 22, 2021 Category: Research Source Type: clinical trials